Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Asphyxia Neonatorum D001238 4 associated lipids
Asthma D001249 52 associated lipids
Pulmonary Atelectasis D001261 1 associated lipids
Behcet Syndrome D001528 7 associated lipids
Birth Weight D001724 23 associated lipids
Blister D001768 16 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Body Weight D001835 333 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Brain Diseases D001927 27 associated lipids
Brain Edema D001929 20 associated lipids
Brain Injuries D001930 4 associated lipids
Bronchial Diseases D001982 3 associated lipids
Bronchial Spasm D001986 18 associated lipids
Bronchiectasis D001987 7 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Burns D002056 34 associated lipids
Burns, Inhalation D002059 4 associated lipids
Carbon Monoxide Poisoning D002249 9 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Poeze M et al. Decreased organ failure in patients with severe SIRS and septic shock treated with the platelet-activating factor antagonist TCV-309: a prospective, multicenter, double-blind, randomized phase II trial. TCV-309 Septic Shock Study Group. 2000 Shock pmid:11049104
Gu M et al. Pharmacologic graft protection without donor pretreatment in liver transplantation from non-heart-beating donors. 2000 Transplantation pmid:11045637
Mul FP et al. Sequential migration of neutrophils across monolayers of endothelial and epithelial cells. 2000 J. Leukoc. Biol. pmid:11037975
Lonardoni MV et al. Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection. 2000 Infect. Immun. pmid:11035745
Rowland BL et al. Elevated circulating concentrations of platelet activating factor in preeclampsia. 2000 Am. J. Obstet. Gynecol. pmid:11035340
Simon HU et al. Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same agonist. 2000 J. Immunol. pmid:11034418
Choi SY et al. Capsaicin inhibits platelet-activating factor-induced cytosolic Ca2+ rise and superoxide production. 2000 J. Immunol. pmid:11034409
Fraga AG et al. Synthesis and pharmacological evaluation of novel heterotricyclic acylhydrazone derivatives, designed as PAF antagonists. 2000 Eur J Pharm Sci pmid:11033071
McLarnon JG et al. Anion channels modulate store-operated calcium influx in human microglia. 2000 Cell Calcium pmid:11032781
De Geest B et al. Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis. 2000 Arterioscler. Thromb. Vasc. Biol. pmid:11031226
Imrie CW and McKay CJ The possible role of platelet-activating factor antagonist therapy in the management of severe acute pancreatitis. 1999 Baillieres Best Pract Res Clin Gastroenterol pmid:11030612
Brady M et al. Cytokines and acute pancreatitis. 1999 Baillieres Best Pract Res Clin Gastroenterol pmid:11030606
Ciesla DJ et al. Hypertonic saline inhibits neutrophil (PMN) priming via attenuation of p38 MAPK signaling. 2000 Shock pmid:11028541
Walther A et al. Role of platelet-activating factor in leukocyte-independent plasma extravasation and mast cell activation during endotoxemia. 2000 J. Surg. Res. pmid:11027469
Montrucchio G et al. Role of platelet-activating factor in cardiovascular pathophysiology. 2000 Physiol. Rev. pmid:11015622
Wagner F et al. Ether lipids in the cell membrane of Mycoplasma fermentans. 2000 Eur. J. Biochem. pmid:11012682
Wratten ML et al. Hemolipodialysis attenuates oxidative stress and removes hydrophobic toxins. 2000 Artif Organs pmid:11012537
Gastaldello K et al. Role of complement and platelet-activating factor in the stimulation of phagocytosis and reactive oxygen species production during haemodialysis. 2000 Nephrol. Dial. Transplant. pmid:11007834
Nieswandt B et al. Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. 2000 Blood pmid:11001906
Zăgrean L et al. Preliminary EEG study of protective effects of Tebonin in transient global cerebral ischemia in rats. 1998 Jan-Jun Rom J Physiol pmid:11000876
Klabunde RE and Anderson DE Obligatory role of nitric oxide in platelet-activating factor-induced microvascular leakage. 2000 Eur. J. Pharmacol. pmid:10996604
Turner PJ et al. Induction by inhibitors of nitric oxide synthase of hyperresponsiveness in the human nasal airway. 2000 Br. J. Pharmacol. pmid:10991932
Kallan NC and Halcomb RL Synthesis of the ring system of phomactin D using a Suzuki macrocyclization. 2000 Org. Lett. pmid:10990428
Suzuki T et al. Thromboxane A(2)-mediated Cl(-) secretion induced by platelet-activating factor in isolated rat colon. 2000 Eur. J. Pharmacol. pmid:10988347
Clark WF et al. A novel treatment for lupus nephritis: lignan precursor derived from flax. 2000 Lupus pmid:10981647
Denizot Y et al. Deregulated platelet-activating factor levels and acetylhydrolase activity in patients with idiopathic IgA nephropathy. 2000 Nephrol. Dial. Transplant. pmid:10978389
Tanaka R et al. Genetics of immunoglobulin A nephropathy. 2000 Ann. Acad. Med. Singap. pmid:10976391
Saito S et al. Modulatory roles of RANTES in IL-4 production by human blood CD4(+)T cells. 2000 Cytokine pmid:10975998
Taguchi R et al. Two-dimensional analysis of phospholipids by capillary liquid chromatography/electrospray ionization mass spectrometry. 2000 J Mass Spectrom pmid:10972995
Kim JD et al. Platelet activating factor acetylhydrolase decreases lung reperfusion injury. 2000 Ann. Thorac. Surg. pmid:10969656
Prescott SM et al. Platelet-activating factor and related lipid mediators. 2000 Annu. Rev. Biochem. pmid:10966465
Wereszczynska-Siemiatkowska U et al. Lysosomal activity of pulmonary alveolar macrophages in acute experimental pancreatitis in rats with reference to positive PAF-antagonist (BN 52021) effect. 2000 Exp. Toxicol. Pathol. pmid:10965985
Durán WN et al. Stimulation of NO production and of eNOS phosphorylation in the microcirculation in vivo. 2000 Microvasc. Res. pmid:10964584
Toró A et al. Transannular Diels-Alder studies on the asymmetric total synthesis of chatancin: the pyranophane approach. 2000 Org. Lett. pmid:10964353
Jeon SY et al. Ultrastructural changes in platelet activating factor-induced epithelial damage in rabbit maxillary sinus mucosa. 2000 Ann. Otol. Rhinol. Laryngol. pmid:10961804
Oktar BK et al. Endothelin-1-induced PMN infiltration and mucosal dysfunction in the rat small intestine. 2000 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:10960346
Maniscalco M et al. The effect of platelet-activating factor (PAF) on nasal airway resistance in healthy subjects is not mediated by nitric oxide. 2000 Allergy pmid:10955702
Gálvez J et al. Intestinal anti-inflammatory activity of UR-12746, a novel 5-ASA conjugate, on acute and chronic experimental colitis in the rat. 2000 Br. J. Pharmacol. pmid:10952687
Soeki T et al. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction. 2000 Jpn. Circ. J. pmid:10952148
Countryman NB et al. Evidence for involvement of the epidermal platelet-activating factor receptor in ultraviolet-B-radiation-induced interleukin-8 production. 2000 J. Invest. Dermatol. pmid:10951245
Martin M et al. [Antiretroviral ant anti-inflammatory properties of a novel platelet activation factor antagonist, PMS-601]. 2000 Pathol. Biol. pmid:10949851
Davenpeck KL et al. Activation of human leukocytes reduces surface P-selectin glycoprotein ligand-1 (PSGL-1, CD162) and adhesion to P-selectin in vitro. 2000 J. Immunol. pmid:10946308
Zhuang Q et al. Activation via multiple signaling pathways induces down-regulation of platelet-activating factor receptors on human B lymphocytes. 2000 J. Immunol. pmid:10946267
Marathe GK et al. Bioactive phospholipid oxidation products. 2000 Free Radic. Biol. Med. pmid:10946218
Ueda T et al. Pancreatitis-associated ascitic fluid increases intracellular Ca(2+) concentration on hepatocytes. 2000 J. Surg. Res. pmid:10945960
Liu JK et al. Paeonilide, a novel anti-PAF-active monoterpenoid-derived metabolite from Paeonia delavayi. 2000 Biosci. Biotechnol. Biochem. pmid:10945272
Kobayashi Y et al. [Inhibitory effect of suplatast tosilate on eosinophil migration]. 2000 Arerugi pmid:10944827
Miyao Y et al. Role of cytokines and adhesion molecules in ischemia and reperfusion in patients with acute myocardial infarction. 1999 Jpn. Circ. J. pmid:10943615
Porta C et al. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF. 2000 Haematologica pmid:10942928
Balestrieri ML and Lee T Regulation of the biosynthesis of acyl analogs of platelet-activating factor by purinergic agonist in endothlial cells. 2000 FEBS Lett. pmid:10940389
Pávó I et al. Interactions of pro-inflammatory and vasoactive mediators with nitric oxide in the regulation of rat vascular permeability during laparotomy. 2000 Eur. J. Pharmacol. pmid:10940373
Baskova I et al. Inhibition of induced and spontaneous platelet aggregation by destabilase from medicinal leech. 2000 Platelets pmid:10938885
Raible DG et al. Hydrogen peroxide release from human eosinophils on fibronectin: scopoletin enhances eosinophil activation. 2000 Free Radic. Biol. Med. pmid:10938462
Miyatake T et al. Analysis of cardiac function during hyperacute rejection: effects of PAF antagonist, TXA(2) inhibitor/antagonists, and nitroglycerin. 2000 Transplant. Proc. pmid:10936319
Haribabu B et al. Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis. 2000 J. Exp. Med. pmid:10934231
Henig NR et al. Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses. 2000 Am. J. Respir. Crit. Care Med. pmid:10934081
Capasso R et al. Preventive effect of eugenol on PAF and ethanol-induced gastric mucosal damage. 2000 Fitoterapia pmid:10930724
Matsunaga Y et al. Regulation of lymphocyte proliferation by eosinophils via chymotrypsin-like protease activity and adhesion molecule interaction. 2000 Br. J. Pharmacol. pmid:10928955
Roudebush WE and Purnell ET Platelet-activating factor content in human spermatozoa and pregnancy outcome. 2000 Fertil. Steril. pmid:10927041
Klyubin IV et al. The role of reactive oxygen species in membrane potential changes in macrophages and astrocytes. 2000 Membr Cell Biol pmid:10926373
O'Brien JG et al. Effects of tranexamic acid and aprotinin, two antifibrinolytic drugs, on PAF-induced plasma extravasation in unanesthetized rats. 2000 Inflammation pmid:10921506
Smalley DM et al. The local effect of PAF on leukocyte adherence to small bowel mesenteric venules following intra-abdominal contamination. 2000 Inflammation pmid:10921505
Choi JH et al. Selective involvement of reactive oxygen intermediates in platelet-activating factor-mediated activation of NF-kappaB. 2000 Inflammation pmid:10921504
Hu GL and Guo HS [Progress in platelet-activating factor receptor research]. 1997 Sheng Li Ke Xue Jin Zhan pmid:10921090
Unno N et al. Plasma platelet-activating factor acetylhydrolase deficiency is associated with atherosclerotic occlusive disease in japan. 2000 J. Vasc. Surg. pmid:10917985
Parrish PR and Larson DF Pharmacological effect of nitroprusside on platelet aggregation. 1999 J Extra Corpor Technol pmid:10915472
Francescangeli E et al. Properties and regulation of microsomal PAF-synthesizing enzymes in rat brain cortex. 2000 Neurochem. Res. pmid:10905633
Baker RR Lipid acetylation reactions and the metabolism of platelet-activating factor. 2000 Neurochem. Res. pmid:10905630
Wang JH and Sun GY Platelet activating factor (PAF) antagonists on cytokine induction of iNOS and sPLA2 in immortalized astrocytes (DITNC). 2000 Neurochem. Res. pmid:10905622
Clark GD et al. Neuronal platelet-activating factor receptor signal transduction involves a pertussis toxin-sensitive G-protein. 2000 Neurochem. Res. pmid:10905621
Parkman HP et al. The contractile action of platelet-activating factor on gallbladder smooth muscle. 2000 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:10898747
Hu L et al. Alkyl and alkoxycarbonyl derivatives of ginkgolide B: synthesis and biological evaluation of PAF inhibitory activity. 2000 Bioorg. Med. Chem. pmid:10896127
Rose F et al. E. coli hemolysin-induced lipid mediator metabolism in alveolar macrophages: impact of eicosapentaenoic acid. 2000 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:10893208
Lee YM et al. Platelet-activating factor contributes to acute lung leak in rats given interleukin-1 intratracheally. 2000 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:10893205
Bailey SR et al. Differential activation of platelets from normal and allergic ponies by PAF and ADP. 2000 Inflamm. Res. pmid:10893045
Folch E et al. H(2)O(2) and PARS mediate lung P-selectin upregulation in acute pancreatitis. 2000 Free Radic. Biol. Med. pmid:10889459
Dent G et al. Involvement of protein tyrosine kinases in activation of human eosinophils by platelet-activating factor. 2000 Immunology pmid:10886400
Aihara M et al. Interaction between neurone and microglia mediated by platelet-activating factor. 2000 Genes Cells pmid:10886367
Tektonidou MG et al. Clinical importance of antibodies against platelet activating factor in antiphospholipid syndrome manifestations. 2000 Eur. J. Clin. Invest. pmid:10886305
Kusuhara H et al. Y-24180, an antagonist of platelet-activating factor, suppresses interleukin 5 production in cultured murine th(2)cells and human peripheral blood mononuclear cells. 2000 Cytokine pmid:10880261
Viswanath M et al. Reduction of hypoxic-ischemic brain swelling in the neonatal rat with PAF antagonist WEB 2170: lack of long-term protection. 2000 Pediatr. Res. pmid:10879808
Xu H et al. Platelet-activating factor acetylhydrolase gene mutation in Japanese children with Escherichia coli O157-associated hemolytic uremic syndrome. 2000 Am. J. Kidney Dis. pmid:10873870
Suzuki S et al. The roles of platelet-activating factor and endothelin-1 in renal damage after total hepatic ischemia and reperfusion. 2000 Transplantation pmid:10868624
Alappatt C et al. Acute keratinocyte damage stimulates platelet-activating factor production. 2000 Arch. Dermatol. Res. pmid:10867814
Bae K et al. Platelet-activating factor (PAF)-dependent transacetylase and its relationship with PAF acetylhydrolases. 2000 J. Biol. Chem. pmid:10867005
Cavallo-Perin P et al. Increased blood levels of platelet-activating factor in insulin-dependent diabetic patients with microalbuminuria. 2000 Nephrol. Dial. Transplant. pmid:10862637
Huo LJ and Yang ZM Effects of platelet activating factor on capacitation and acrosome reaction in mouse spermatozoa. 2000 Mol. Reprod. Dev. pmid:10862011
Denizot Y et al. Effect of cytokines and lipid mediators on the synthesis of interleukin 1 beta by human bone marrow stromal cells. 2000 Cytokine pmid:10857767
Nakajima T et al. Phospholipase A2-mediated superoxide production of murine peritoneal macrophages induced by chrysotile stimulation. 2000 Int. J. Biochem. Cell Biol. pmid:10856708
Caslake MJ et al. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease. 2000 Atherosclerosis pmid:10856534
Zhu X et al. A surrogate method for assessment of beta(2)-integrin-dependent adhesion of human eosinophils to ICAM-1. 2000 J. Immunol. Methods pmid:10854610
Fukuyama S et al. Effect of eotaxin and platelet-activating factor on airway inflammation and hyperresponsiveness in guinea pigs in vivo. 2000 Am. J. Respir. Crit. Care Med. pmid:10852755
Poveshchenko AF and Kozlov VA [The effect of platelet-activating factor and its antagonist--BN 52021--on immune reactions in vivo in mice and in vitro]. 1999 Jul-Aug Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:10852052
Kobayashi N et al. Transepithelial migration of activated eosinophils induces a decrease of E-cadherin expression in cultured human nasal epithelial cells. 2000 Clin. Exp. Allergy pmid:10848899
Ma X and Bazan HE Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing. 2000 Invest. Ophthalmol. Vis. Sci. pmid:10845588
Serradji N et al. Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replication. 2000 J. Med. Chem. pmid:10841793
Mizutani Y et al. Cloning and expression of rat neutral sphingomyelinase: enzymological characterization and identification of essential histidine residues. 2000 Biochim. Biophys. Acta pmid:10832103
Tokumura A et al. Structural identification of phosphatidylcholines having an oxidatively shortened linoleate residue generated through its oxygenation with soybean or rabbit reticulocyte lipoxygenase. 2000 J. Lipid Res. pmid:10828088
Asai Y et al. Characterization of the physicochemical properties of the micelles of platelet-activating factor (C18:0). 2000 Drug Dev Ind Pharm pmid:10826115
Ohishi S [Evaluation of time course and inter-relationship of inflammatory mediators in experimental inflammatory reaction]. 2000 Yakugaku Zasshi pmid:10825809